{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:27:25Z","timestamp":1760142445118,"version":"build-2065373602"},"reference-count":89,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.annfar.2008.04.002","type":"journal-article","created":{"date-parts":[[2008,5,9]],"date-time":"2008-05-09T05:45:58Z","timestamp":1210311958000},"page":"405-415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Contraception orale, traitement hormonal de la m\u00e9nopause\u00a0: risque thromboembolique et implications p\u00e9riop\u00e9ratoires"],"prefix":"10.1016","volume":"27","author":[{"given":"V.","family":"Chalhoub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Edelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Staiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Benhamou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annfar.2008.04.002_bib1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.contraception.2004.07.009","article-title":"Progestogen-only contraception in women at high risk of venous thromboembolism","volume":"70","author":"Conard","year":"2004","journal-title":"Contraception"},{"issue":"359","key":"10.1016\/j.annfar.2008.04.002_bib2","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0140-6736(02)08298-3","article-title":"Risk of venous thromboembolism and oral contraceptives","volume":"13","author":"Gompel","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.annfar.2008.04.002_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/jama.1963.03060020091034","article-title":"Oral contraception and venous thrombosis","volume":"13","author":"Tyler","year":"1963","journal-title":"JAMA"},{"key":"10.1016\/j.annfar.2008.04.002_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/bmj.2.5703.203","article-title":"Thromboembolic disease and the steroidal content of oral contraceptives. A report to the committe on Safety of Drugs","volume":"2","author":"Inman","year":"1970","journal-title":"BMJ"},{"key":"10.1016\/j.annfar.2008.04.002_bib5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/oxfordjournals.aje.a115799","article-title":"Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease","volume":"133","author":"Gerstman","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.annfar.2008.04.002_bib6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.contraception.2004.09.005","article-title":"Twenty micrograms vs. >20 microg estrogen oral contraceptives for contraception: systematic review of randomized controlled trials","volume":"71","author":"Gallo","year":"2005","journal-title":"Contraception"},{"issue":"142","key":"10.1016\/j.annfar.2008.04.002_bib7","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0002-9378(16)32485-1","article-title":"Progestogens and arterial disease--evidence from the Royal College of General Practitioners\u2019 study","volume":"15","author":"Kay","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2008.04.002_bib8","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJM199011153232003","article-title":"The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism","volume":"15","author":"Godsland","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annfar.2008.04.002_bib9","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.annfar.2008.04.002_bib10","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.annfar.2008.04.002_bib11","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"16","author":"Jick","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.annfar.2008.04.002_bib12","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen","volume":"16","author":"Bloemenkamp","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.annfar.2008.04.002_bib13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJM198109173051205","article-title":"Oral contraceptives and cardiovascular disease (second of two parts)","volume":"305","author":"Stadel","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annfar.2008.04.002_bib14","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1056\/NEJM198109103051104","article-title":"Oral contraceptives and cardiovascular disease (first of two parts)","volume":"305","author":"Stadel","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annfar.2008.04.002_bib15","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJM200105173442007","article-title":"Oral contraceptives and the risk of venous thrombosis","volume":"17","author":"Vandenbroucke","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annfar.2008.04.002_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thrombosis: meta-analysis","volume":"323","author":"Kemmeren","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.annfar.2008.04.002_bib17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0010-7824(97)00119-4","article-title":"First-time use of newer oral contraceptives and the risk of venous thromboembolism","volume":"56","author":"Suissa","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.annfar.2008.04.002_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/bmj.326.7383.257","article-title":"Thromboembolism associated with the new contraceptive Yasmin","volume":"326","author":"van Groothest","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.annfar.2008.04.002_bib19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1365-2125.2005.02373.x","article-title":"Deep vein thrombosis and pulmonary embolism reported in the Prescription Event Monitoring Study of Yasmin","volume":"60","author":"Pearce","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.annfar.2008.04.002_bib20","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.0001-6349.2004.00574.x","article-title":"Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users","volume":"83","author":"Samuelsson","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.annfar.2008.04.002_bib21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10654-005-4266-7","article-title":"Mortality from venous thromboembolism in young Swedish women and its relation to pregnancy and use of oral contraceptives - an approach to specifying rates","volume":"20","author":"Samuelsson","year":"2005","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.annfar.2008.04.002_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-125-1-199607010-00001","article-title":"The long-term clinical course of acute deep venous thrombosis","volume":"125","author":"Prandoni","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annfar.2008.04.002_bib23","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1001\/jama.293.19.2352","article-title":"Thrombophilia, clinical factors, and recurrent venous thrombotic events","volume":"293","author":"Christiansen","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.annfar.2008.04.002_bib24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.contraception.2005.08.011","article-title":"Does use of hormonal contraceptives among women with thrombogenic mutations increase their risk of venous thromboembolism? A systematic review","volume":"73","author":"Mohllajee","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.annfar.2008.04.002_bib25","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.annfar.2008.04.002_bib26","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0015-0282(99)00318-0","article-title":"Screening for factor V Leiden mutation before prescribing combination oral contraceptives","volume":"72","author":"Creinin","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.annfar.2008.04.002_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0010-7824(98)00041-9","article-title":"Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives","volume":"57","author":"World Health Organisation","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.annfar.2008.04.002_bib28","first-page":"539","article-title":"Safety and efficacy of levonorgestrel implant, intrauterine device, and sterilization","volume":"97","author":"Meirik","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2008.04.002_bib29","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0140-6736(99)04394-9","article-title":"Risk of idiopathic venous thromboembolism in users of progestagens alone","volume":"354","author":"Vasilakis","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.annfar.2008.04.002_bib30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0010-7824(98)00045-6","article-title":"A randomized controlled double-blind study of the effects on haemostasis of two progestogen-only pills containing 75 microgram desogestrel or 30 microgrammes levonorgestrel","volume":"57","author":"Winkler","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.annfar.2008.04.002_bib31","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0002-9378(87)80129-1","article-title":"Coagulation effects of oral contraception","volume":"157","author":"Bonnar","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2008.04.002_bib32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0038-1657546","article-title":"Effect of oral contraceptives on haemostasis variables","volume":"78","author":"Kluft","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.annfar.2008.04.002_bib33","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0140-6736(99)06092-4","article-title":"Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study","volume":"11","author":"Rosing","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.annfar.2008.04.002_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0037-1613959","article-title":"Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives","volume":"84","author":"Meijers","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.annfar.2008.04.002_bib35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1055\/s-0037-1613958","article-title":"Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study","volume":"84","author":"Middeldorp","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.annfar.2008.04.002_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1067\/mob.2003.344","article-title":"Low-dose oral contraceptive effects on thromboelastogram criteria and relationship to hypercoagulability","volume":"189","author":"Zahn","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2008.04.002_bib37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/bmj.3.5715.123","article-title":"Postoperative thromboembolism and the use of oral contraceptives","volume":"3","author":"Vessey","year":"1970","journal-title":"BMJ"},{"key":"10.1016\/j.annfar.2008.04.002_bib38","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2105\/AJPH.62.5.680","article-title":"Oral contraceptive use in patients with thromboembolism following surgery, trauma, or infection","volume":"62","author":"Greene","year":"1972","journal-title":"Am J Public Health"},{"key":"10.1016\/j.annfar.2008.04.002_bib39","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(76)90296-8","article-title":"Oral contraceptives, antithrombin- III activity, and postoperative deep-vein thrombosis","volume":"6","author":"Sagar","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.annfar.2008.04.002_bib40","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2141.1980.tb06018.x","article-title":"Deep vein thrombosis and changes in coagulation and fibrinolysis after gynaecological operations in Chinese: the effect of oral contraceptives and malignant disease","volume":"46","author":"Tso","year":"1980","journal-title":"Br J Haematol"},{"key":"10.1016\/j.annfar.2008.04.002_bib41","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0049-3848(84)90283-4","article-title":"Oral contraceptives and surgery: reduced antithrombin and antifactor Xa levels without postoperative venous thrombosis in low-risk patients","volume":"35","author":"Gallus","year":"1984","journal-title":"Thromb Res"},{"key":"10.1016\/j.annfar.2008.04.002_bib42","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/bmj.292.6519.526","article-title":"Oral contraceptives and venous thromboembolism: findings in a large prospective study","volume":"292","author":"Vessey","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.annfar.2008.04.002_bib43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/bmj.2.4519.269","article-title":"Changes in haemostasis after stopping the combined contraceptive pill: implications for major surgery","volume":"2","author":"Robinson","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.annfar.2008.04.002_bib44","first-page":"634","article-title":"Oral contraceptives and venous thromboses in adolescents undergoing elective surgery: a case report, and review of the literature","volume":"13","author":"Taube","year":"1992","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.annfar.2008.04.002_bib45","unstructured":"WHOMEC: World Health Organization. Medical Eligibility Criteria for Contraceptive use. Geneva; 2000."},{"key":"10.1016\/j.annfar.2008.04.002_bib46","unstructured":"Scottish Intercollegiate Guidelines Network (SGIN). Prophylaxis of venous thromboembolism. SIGN Publication No. 62. Edinburgh; 2002."},{"key":"10.1016\/j.annfar.2008.04.002_bib47","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3109\/00016349409006274","article-title":"A prospective study of fertility and outcome of pregnancy after discontinuation of oral contraception in relation to elective orthopedic surgery","volume":"73","author":"Dale","year":"1994","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.annfar.2008.04.002_bib48","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.annfar.2005.06.011","article-title":"Pr\u00e9vention de la maladie thromboembolique veineuse p\u00e9riop\u00e9ratoire et obst\u00e9tricale","volume":"24","author":"Samama","year":"2005","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.annfar.2008.04.002_bib49","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-132-9-200005020-00002","article-title":"Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen\/progestin Replacement Study","volume":"132","author":"Grady","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annfar.2008.04.002_bib50","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1056\/NEJM200008243430801","article-title":"Effects of estrogen replacement on the progression of coronary-artery atherosclerosis","volume":"343","author":"Herrington","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annfar.2008.04.002_bib51","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.annfar.2008.04.002_bib52","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1001\/jama.289.20.2717","article-title":"Hormone therapy and the brain\u00a0: d\u00e9j\u00e0 vu all over again?","volume":"289","author":"Yaffe","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.annfar.2008.04.002_bib53","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1001\/jama.290.13.1739","article-title":"Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial","volume":"290","author":"Anderson","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.annfar.2008.04.002_bib54","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial","volume":"290","author":"Cauley","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.annfar.2008.04.002_bib55","doi-asserted-by":"crossref","unstructured":"L\u00ea MG. Impact des articles r\u00e9cents sur l\u2019\u00e9tude de la relation entre THS et cancer du sein. R\u00e9ponse aux courriers de Drapier-Faure E, Jamin C et Br\u00e9art G, Ringa V. Gynecol Obstet Fertil 2003;31:193\u20134.","DOI":"10.1016\/S1297-9589(03)00016-X"},{"key":"10.1016\/j.annfar.2008.04.002_bib56","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/bmj.328.7436.371","article-title":"Benefits and harms associated with hormone replacement therapy: clinical decision analysis","volume":"328","author":"Minelli","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.annfar.2008.04.002_bib57","unstructured":"Afssaps. Mise au point actualis\u00e9e sur le traitement hormonal substitutif de la m\u00e9nopause \u2013Afssaps, D\u00e9cembre 2003."},{"issue":"33","key":"10.1016\/j.annfar.2008.04.002_bib58","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0368-2315(04)96440-X","article-title":"Alternatives to hormone replacement therapy for menopause: an epidemiological evaluation","author":"Ringa","year":"2004","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.annfar.2008.04.002_bib59","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.ajog.2004.04.041","article-title":"Dose of progestin in postmenopausal-combined hormone therapy and risk of endometrial cancer","volume":"191","author":"Reed","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2008.04.002_bib60","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/jama.292.13.1581","article-title":"Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis","volume":"292","author":"Smith","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.annfar.2008.04.002_bib61","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1067\/S0002-9378(03)00599-4","article-title":"Effects of low-dose oral and transdermal estrogen replacement therapy on hemostatic factors in healthy postmenopausal women: a randomized placebo-controlled study","volume":"189","author":"Post","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2008.04.002_bib62","first-page":"395","article-title":"Hormone replacement therapy and risk for venous thromboembolism: what's new and how do these findings influence clinical practice?","volume":"12","author":"Douketis","year":"2005","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.annfar.2008.04.002_bib63","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(96)07113-9","article-title":"Risk of venous thromboembolism in users of hormone replacement therapy","volume":"348","author":"Daly","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.annfar.2008.04.002_bib64","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0140-6736(96)07114-0","article-title":"Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens","volume":"348","author":"Jick","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.annfar.2008.04.002_bib65","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(03)14066-4","article-title":"Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk","volume":"362","author":"Scarabin","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.annfar.2008.04.002_bib66","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women. Impact of the route of estrogen administration and progestogens: the ESTHER study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.annfar.2008.04.002_bib67","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/CIRCULATIONAHA.106.675405","article-title":"Are some types of hormone therapy safer than others? Lessons from the estrogen and thromboembolism risk study","volume":"115","author":"Rexrode","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.annfar.2008.04.002_bib68","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1055\/s-0037-1613857","article-title":"Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45\u201364 years. Relationships to hormone replacement therapy","volume":"83","author":"Lowe","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.annfar.2008.04.002_bib69","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1161\/CIRCULATIONAHA.105.565556","article-title":"Prothrombic mutations, hormone therapy, and venous thromboembolism among postmenopausal women. Impact of the route of estrogen administration","volume":"112","author":"Straczek","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.annfar.2008.04.002_bib70","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1055\/s-0037-1615889","article-title":"Effects of hormone replacement therapy on coagulation, fibrinolysis, and thrombosis risk in postmenopausal women","volume":"82","author":"Koh","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.annfar.2008.04.002_bib71","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1471-0528.2003.02165.x","article-title":"Hormone replacement therapy and hypercoagulability. Results from the Prospective Collaborative Danish Climacteric Study","volume":"110","author":"Sidelmann","year":"2003","journal-title":"BJOG"},{"issue":"273","key":"10.1016\/j.annfar.2008.04.002_bib72","first-page":"199","article-title":"Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial","volume":"18","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.annfar.2008.04.002_bib73","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1001\/archinte.160.21.3315","article-title":"Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women","volume":"160","author":"Davidson","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.annfar.2008.04.002_bib74","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/13697130500345109","article-title":"Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article","volume":"8","author":"Lakoski","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.annfar.2008.04.002_bib75","doi-asserted-by":"crossref","first-page":"E261","DOI":"10.1152\/ajpendo.00550.2005","article-title":"Estrogen and progestagens differentially modulate vascular proinflammatory factors","volume":"291","author":"Sunday","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.annfar.2008.04.002_bib76","first-page":"507","article-title":"Hormone replacement therapy is safe in women undergoing coronary artery bypass grafting","volume":"32","author":"Nussmeier","year":"2005","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.annfar.2008.04.002_bib77","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1067\/mtc.2002.126225","article-title":"Hormone replacement therapy is associated with improved survival in women undergoing coronary artery bypass grafting","volume":"124","author":"Nussmeier","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.annfar.2008.04.002_bib78","first-page":"732","article-title":"Estrogen therapy in women undergoing coronary artery bypass grafting: effect on surgical complications","volume":"95","author":"Shackelford","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2008.04.002_bib79","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0002-9149(97)00001-5","article-title":"Effect on survival of estrogen replacement therapy after coronary artery bypass grafting","volume":"1","author":"Sullivan","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.annfar.2008.04.002_bib80","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/archsurg.1996.01430140050013","article-title":"Correcting prolonged bleeding during renal transplantation with estrogen or plasma","volume":"131","author":"Boyd","year":"1996","journal-title":"Arch Surg"},{"key":"10.1016\/j.annfar.2008.04.002_bib81","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1213\/00000539-199806000-00008","article-title":"Conjugated estrogen reduces transfusion and coagulation factor requirements in orthotopic liver transplantation","volume":"86","author":"Frenette","year":"1998","journal-title":"Anesth Analg"},{"key":"10.1016\/j.annfar.2008.04.002_bib82","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/humrep\/del498","article-title":"A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulability","volume":"22","author":"Skouby","year":"2007","journal-title":"Human Reprod"},{"key":"10.1016\/j.annfar.2008.04.002_bib83","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0015-0282(00)00587-2","article-title":"Effect of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: a multicenter, double-blind, randomized study","volume":"74","author":"Winkler","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.annfar.2008.04.002_bib84","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.maturitas.2006.04.012","article-title":"Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation","volume":"55","author":"Eilertsen","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.annfar.2008.04.002_bib85","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1471-0528.2003.02035.x","article-title":"Interaction between hormone replacement therapy preparations and oral anticoagulant therapy","volume":"110","author":"McLintock","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.annfar.2008.04.002_bib86","first-page":"1233","article-title":"Predictors of difficulty when discontinuing postmenopausal hormone therapy","volume":"102","author":"Grady","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2008.04.002_bib87","unstructured":"Royal College of Obstetricians and Gynaecologists Guidelines. Guideline No 19. Hormone replacement therapy and venous thromboembolism. 2000 (revised 2004) www.rcog.org.uk\/guidelines\/guideline19.html."},{"key":"10.1016\/j.annfar.2008.04.002_bib88","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/bja\/86.5.709","article-title":"Hormone replacement therapy (HRT) and anaesthesia","volume":"86","author":"Brighouse","year":"2001","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.annfar.2008.04.002_bib89","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0002-9610(00)00331-7","article-title":"Estrogen replacement therapy and the surgeon","volume":"179","author":"Shackelford","year":"2000","journal-title":"Am J Surg"}],"container-title":["Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0750765808001627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0750765808001627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:07:37Z","timestamp":1760090857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0750765808001627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":89,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0750765808001627"],"URL":"https:\/\/doi.org\/10.1016\/j.annfar.2008.04.002","relation":{},"ISSN":["0750-7658"],"issn-type":[{"type":"print","value":"0750-7658"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contraception orale, traitement hormonal de la m\u00e9nopause\u00a0: risque thromboembolique et implications p\u00e9riop\u00e9ratoires","name":"articletitle","label":"Article Title"},{"value":"Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annfar.2008.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}